The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness

International Journal for Parasitology
Luc Vanhamme, Etienne Pays

Abstract

Trypanosoma brucei brucei infects a wide range of mammals but is unable to infect humans because this subspecies is lysed by normal human serum (NHS). The trypanosome lytic factor is associated with High Density Lipoproteins (HDLs). Several HDL-associated components have been proposed as candidate lytic factors, and contradictory hypotheses concerning the mechanism of lysis have been suggested. Elucidation of the process by which Trypanosoma brucei rhodesiense resists lysis and causes human sleeping sickness has indicated that the HDL-bound apolipoprotein L-I (apoL-I) could be the long-sought after lytic component of NHS. This research also allowed the identification of a specific diagnostic DNA probe for T. b. rhodesiense, and may lead to the development of novel anti-trypanosome strategies for use in the field.

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M R Rifkin
Sep 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·M P Gillett, J S Owen
Mar 1, 1990·Molecular and Biochemical Parasitology·G HideA Tait
Sep 1, 1990·The Journal of protozoology·J R SeedM R Loomis
Mar 1, 1990·Journal of Internal Medicine·I Nilsson-Ehle, P Nilsson-Ehle
Sep 1, 1989·Molecular and Biochemical Parasitology·C De GreefR Hamers
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B Smith, S L Hajduk
Jul 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·P LorenzB Betschart
Mar 1, 1995·Molecular and Biochemical Parasitology·S TomlinsonV Nussenzweig
Jan 1, 1994·Annual Review of Microbiology·S L HajdukJ D Esko
Mar 1, 1994·Molecular and Biochemical Parasitology·P LorenzB Betschart
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D M LevineA L Rubin
Feb 1, 1996·Molecular and Biochemical Parasitology·J RaperS Tomlinson
Mar 28, 1998·The Journal of Biological Chemistry·M MuranjanS Tomlinson
Mar 20, 1999·Infection and Immunity·J RaperS Tomlinson
Jul 31, 1999·The Journal of Biological Chemistry·O SørensenN Borregaard
Dec 11, 1999·Molecular and Biochemical Parasitology·J D Milner, S L Hajduk
Nov 9, 2000·Molecular and Biochemical Parasitology·M P Molina PortelaS Tomlinson
Nov 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·A MacLeodA Tait
May 16, 2001·The Journal of Biological Chemistry·J DrainS L Hajduk
May 18, 2001·Molecular and Biochemical Parasitology·P Borst, S Ulbert
Jun 23, 2001·Molecular and Biochemical Parasitology·M ShimamuraS L Hajduk
Jun 26, 2001·Trends in Parasitology·L VanhammeJ D Barry
Aug 10, 2001·Current Opinion in Microbiology·J RaperS Tomlinson
Aug 23, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A MacLeodC M Turner
Oct 19, 2001·Molecular and Biochemical Parasitology·C BarkerS L Hajduk
Nov 13, 2001·Molecular and Biochemical Parasitology·J R BishopS L Hajduk
Jan 30, 2002·Molecular and Biochemical Parasitology·Seigo HatadaNobuyo Maeda

❮ Previous
Next ❯

Citations

Oct 17, 2009·Lancet·Reto BrunChristian Burri
Aug 10, 2006·Eukaryotic Cell·Sara D FaulknerAndrew G McArthur
Sep 27, 2013·PLoS Neglected Tropical Diseases·Philippe TrucMarc Desquesnes
Sep 12, 2007·PLoS Pathogens·Justin WidenerStephen Hajduk
Feb 26, 2010·Journal of Biomedicine & Biotechnology·Toya Nath Baral
May 6, 2008·Diagnostic Microbiology and Infectious Disease·Stijn DeborggraevePhilippe Büscher
Feb 8, 2005·Molecular and Biochemical Parasitology·Laurence LecordierLuc Vanhamme
Oct 6, 2005·Molecular and Biochemical Parasitology·Maria del Pilar Molina-PortelaJayne Raper
Jun 30, 2006·Expert Opinion on Pharmacotherapy·Martin Braddock
Jul 22, 2010·Trends in Parasitology·Richard J Wheeler
Dec 9, 2009·International Journal for Parasitology·De-Hua LaiZhao-Rong Lun
May 1, 2016·Current Opinion in Microbiology·Isabel RoditiArunasalam Naguleswaran
Dec 5, 2006·Anais Da Academia Brasileira De Ciências·Philippe Vincendeau, Bernard Bouteille
May 9, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Man Chin ChungLorena Blau
Apr 11, 2006·Nature Medicine·Toya Nath BaralPatrick De Baetselier
Aug 21, 2018·PLoS Neglected Tropical Diseases·Emilie DamaVincent Jamonneau
May 20, 2006·Nature Reviews. Microbiology·Etienne PaysDavid Pérez-Morga
Jul 28, 2005·The Journal of Biological Chemistry·April M ShiflettStephen L Hajduk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.